| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.051 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |